Mostafa Kamal to succeed Ken Paulus as Prime Therapeutics’ President and Chief Executive Officer
Paulus to retire after a storied career in health care (Eagan, MN) — July 3, 2023 — Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, today announced that Mostafa Kamal will succeed Ken Paulus as President and CEO of Prime Therapeutics. Kamal currently serves as president of Prime Therapeutics, and the CEO of Magellan Rx, a Prime Therapeutics company. His new role elevates him to include